← All companies
Amylyx Pharmaceuticals, Inc.
AMLX - CIK 0001658551
Market cap$1.50 B
Rank#2318
SEC filings403
The table below shows Amylyx Pharmaceuticals, Inc.'s balance sheet by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q1 2026 | Q3 2025 | Q2 2025 | Q1 2025 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $229.14M | $225.18M | $58.09M | $59.76M | $71.84M | $75.00M |
| Short-term investments | - | - | - | - | - | $234.81M |
| Receivables | - | $132.00K | $103.00K | $300.00K | $1.73M | $4.09M |
| Inventory | - | - | - | - | $38.32M | $38.32M |
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.